The most recent short interest data has been released for the 06/15/2017 settlement date, which shows a 721,576 share decrease in total short interest for SciClone Pharmaceuticals, Inc. (SCLN), to 846,255, a decrease of 46.02% since 05/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for SCLN at the 06/15/2017 settlement increased to 1,493,546, as compared to 256,337 at the 05/31/2017 report. That brought "days to cover" down to 1.00, a 83.65% decrease from the 6.12 days to cover calculated at the previous short interest data release.The below chart shows the historical "days to cover" for SCLN at previous short interest release dates: A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where SCLN had been shorted as a hedge. The chart below shows the one year performance of SCLN shares, versus its 200 day moving average. Looking at this chart, SCLN's low point in its 52 week range is $8.55 per share, with $13.73 as the 52 week high point — that compares with a last trade of $10.90.
More from Stocks
Netflix and IBM Earnings Spark Negative Response, but Microsoft Will Be Key
There are still stock-picking opportunities, but tighten stops and don't let losses build.
Dow Futures Flat , Global Stocks Slip, as Tech Earnings, Trade Data Rattle Bulls
U.S. equity futures are pointing to a third day of declines on Wall Street Thursday as investors react to weaker-than-expected earnings in the tech and industrial sectors and signal increasing concern for the fate of U.S.-China trade talks.
Honeywell Beats Q2 Profit Forecast, Lifts 2019 Guidance, as Aerospace Shines
Honeywell posted stronger-than-expected second quarter earnings Thursday, and boosted its full-year profit guidance, as it aerospace division recorded double-digit sales growth thanks to strength in its U.S. and international defense and space business.